Topical use of tranexamic acid can reduce opioid consumption compared with intravenous use for patients undergoing primary total hip arthroplasty: a prospective randomized controlled trial 1. In this prospective randomized controlled study, pain scores for the topical tranexamic acid (TXA) group on the first day after total hip arthroplasty (THA) were significantly lower than the